Table 1.

Concentrations and ratios of inflammatory mediators in exudates and plasma on day 1 after thioglycollate treatment in vivo *.

	Exudates (A, n = 3)	Plasma (B, n = 4)	Ratio of mean value between A and B
FGF-9	2.60 ± 0.26	2.23 ± 0.51	1.17
KC/GRO	11.33 ± 2.33	335.00 ± 127.05	0.03
IFN-γ	14.00 ± 1.53	10.90 ± 3.52	1.28
IP-10	114.00 ± 16.70	117.50 ± 5.72	0.97
IL-1α	170.33 ± 3.53	282.00 ± 71.17	0.60
IL-6	18.67 ± 0.67	14.65 ± 4.24	1.27
IL-17A	6.23 ± 0.92	2.81 ± 1.62	2.22
Lymphotactin**	38.70 ± 1.45	98.00 ± 5.28	0.40
MIP-1β**	3373.33 ± 274.73	610.25 ± 105.45	5.53
MIP-2	26.70 ± 0.67	35.75 ± 10.38	9.75
MCP-1	1069.33 ± 341.10	364.25 ± 65.35	2.94
MCP-3	2193.33 ± 579.55	970.50 ± 64.64	2.26
MCP-5	89.00 ± 21.50	69.25 ± 1.65	1.29
OSM	260.00 ± 17.32	231.25 ± 79.01	1.12
SCF	707.00 ± 21.55	1084.50 ± 198.52	0.65
RANTES***	0.09 ± 0.01	0.04 ± 0.00	2.17
TIMP-1**	38.67 ± 3.18	7.40 ± 0.85	5.23
TNF-α**	71.67 ± 2.96	35.75 ± 2.93	2.01
VEGF-A	820.33 ± 18.44	943.00 ± 109.18	0.87

*The unit for all concentrations is pg/mL, except FGF-9 and TIMP-1 as ng/mL.

**P < 0.001.

***P < 0.05.

All other samples P > 0.05.